The Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a breakthrough in cancer treatment. Clinical trials conducted globally have shown promising results in end stage patients, especially in patients suffering from Acute Lymphocytic Leukemia. Though this technology has a remarkable therapeutic potential for cancer patients, at present this technology is not available in India. Each patient's CAR-T cell therapy costs 3-4 crore (INR).
- Read more about CAR - T cell therapy, new milestone for India
- Log in or register to post comments
source https://www.pharmatutor.org/content/pharmapedia/car-t-cell-therapy-new-milestone-for-india
No comments:
Post a Comment